Benzinga's Top Downgrades
Analysts at Jefferies downgraded PAREXEL International (NASDAQ: PRXL) from “buy” to “hold.” PAREXEL's shares closed at $32.38 yesterday. PAREXEL's trailing-twelve-month ROA is 4.01%.
Analysts at Citigroup downgraded ArcelorMittal (NYSE: MT) from “buy” to “neutral.” ArcelorMittal's shares closed at $14.65 yesterday. ArcelorMittal's trailing-twelve-month profit margin is 0.69%.
Analysts at Goldman Sachs downgraded MeadWestvaco (NYSE: MWV) from “buy” to “neutral.” MeadWestvaco's shares closed at $31.20 yesterday. MeadWestvaco's PEG ratio is 2.16.
RBC Capital downgraded Endo Health Solutions (NASDAQ: ENDP) from “outperform” to “sector perform.” Endo Health's shares closed at $31.51 yesterday. Endo Health's trailing-twelve-month ROA is 5.13%.
Latest Ratings for PRXL
|Apr 2016||Avondale Partners||Maintains||Underperform|
|Mar 2016||SunTrust Robinson Humphrey||Upgrades||Neutral||Buy|
|Jan 2016||Avondale Partners||Downgrades||Market Perform||Market Underperform|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.